Class IIa Medical Device · Patent-pending

NeuroCharge

AI-driven oral biosensing dedicated to reducing ADHD wait times and accelerating diagnostic accuracy through real-time ANS monitoring.

Join the waitlist Our Mission
HRV/EDA Biosensing
Proactive Stress Management
Clinical Titration Support

The ADHD Game-Changer

By bridging the gap between hospital and home, NeuroCharge provides the objective physiological data needed to speed up diagnosis and personalize treatment pathways.

Solving the Diagnostic Crisis

Millions of neurodivergent individuals face years of waiting for answers. NeuroCharge is a non-invasive platform that monitors autonomic nervous system (ANS) dysregulation, providing clinicians with the real-time data required to shorten titration periods and deliver instantaneous digital biofeedback.

Continuous Monitoring

Captures HRV + EDA signals to anticipate stress before burnout occurs.

Faster Titration

Objective data helps clinicians find the right medication balance in weeks, not months.

Empowered Patients

Real-time insights for neurodivergent individuals to manage cognitive load proactively.

NeuroCharge AI Biosensing Logo

Our Mission

NeuroCharge was founded by Amal Omar to bring empathy and physiological precision to the ADHD community. As a neurodivergent founder, Amal is leading the development of this Class IIa medical device to bridge the gap in ADHD care. By monitoring ANS dysregulation through real-time HRV and EDA data, we aim to shorten titration periods and empower individuals with proactive stress management tools.

Join the Waitlist

Help us lead the shift toward personalized neuro-support. Join our early pilots.

To join the waitlist, please open the form in a new tab.

Only NeuroCharge updates. Unsubscribe anytime.